Special Adviser

• Feb 2023 - Present

Principal Consultant

• Jan 2023 - Present

- Provide consulting advice and strategic support to pharmaceutical and biotechnology organizations in fields of market access, reimbursement, and payer value proposition development. - Help people who are shaping tomorrow's health outcomes by offering strategic, insightful solutions for successful market access in our ever-changing healthcare environment. - Propose integrated approaches to value / access identification, quantification, and communication, starting early in development and spanning product life cycle for maximum success in today’s competitive market. Show less

Director, Value & Access | New Product Planning

• 2020 - 2022

- Responsible to develop and implement strategies for the entire pipeline to optimize clinical development programs, RWE generation, early stakeholders’ engagement to ensure a seamless access/reimbursement introduction of innovative medicines in Canada.- Assist and advise the Leadership Team on investment decisions and asset prioritization- Play a critical role in early medicine development processes to guide and consult regional and global functions in the specific needs of the Canadian market and especially the payer environment. Execution of innovative Patient access projects.- Build, motivate and lead a cross-functional team of 30+ individuals within Canadian affiliate (Medical Affairs, Regulatory Affairs, Clinical Operations, Value & Access, Marketing, Stakeholder engagement)- Country RWE Ambassador and member of the Canadian Value & Access Lead Team. Show less

Director, HE & Patient Access | Neuroscience and Cardio-Metabolic portfolios

• 2015 - 2020

- Responsible for achieving access and maintaining optimal pricing, reimbursement, and ultimately ensuring Novartis innovative medicines are readily available to appropriate patients through private and public drug plans.- Manage 5 direct reports to create end-to-end price and reimbursement strategies, including the public and private value propositions; comprehensive value dossiers to HTA agencies (CADTH and INESSS) and provincial drug plans; and execution of payer contracting strategies to optimize access.- HE&OR Center of Excellence Lead, member of the Value & Access and Commercial Lead Teams. Show less

Market Access & Gov. Affairs | CNS & Oncology portfolios | Quebec & Atlantic

• Feb 2013 - Sep 2015

- Lead payer, pricing and negotiation strategies to gain or improve the market access for the CNS & Oncology portfolios. - Build valuable relationships with key stakeholders including bureaucrats, policy makers, patient groups, academia, hospital pharmacists & medical experts and life science community. - Represent Lundbeck at key Institutional meetings and Innovative Medicines Canada’s regional committees. - Lead payer, pricing and negotiation strategies to gain or improve the market access for the CNS & Oncology portfolios. - Build valuable relationships with key stakeholders including bureaucrats, policy makers, patient groups, academia, hospital pharmacists & medical experts and life science community. - Represent Lundbeck at key Institutional meetings and Innovative Medicines Canada’s regional committees.

Speciality Sales Representative

• 2012 - 2013

Development program - short term assignment as a Speciality Sales Representative for McGill-CHUM-Montreal Areas

Manager, HE, Reimb’t Strategy & Pricing

• 2007 - 2012

Lead payer, pricing, and data generation strategies, including real-world data in partnership with academia, to support HTA assessment in Canada (CADTH and INESSS) and to gain and improve access and product listings.

Associate Manager, HE&OR

• 2005 - 2007

Manager, HE&OR

• 2004 - 2005

Value demonstration/ market access consulting work fits with the client’s strategic goals: execution and delivery of payer value dossiers, HTA submissions (BIA, CEA, BoI), payer value stories, landscape analyses, stakeholder identification, primary research, systematic literature review and evidence synthesis activities. Value demonstration/ market access consulting work fits with the client’s strategic goals: execution and delivery of payer value dossiers, HTA submissions (BIA, CEA, BoI), payer value stories, landscape analyses, stakeholder identification, primary research, systematic literature review and evidence synthesis activities.

BioAgral, Director and Managing Principal

• 2001 - 2004

Reporting to the board of directors, led the team (3 direct reports and multiple consultants) to successfully develop impactful projects, represented the organization with private and public partners to achieve BioAgral’s mission: Quebec Ag-biotech network aiming to mobilize all players in this key sector of innovation to promote the Agri-Food, Veterinary and Agri-Environmental Biotechnology. Reporting to the board of directors, led the team (3 direct reports and multiple consultants) to successfully develop impactful projects, represented the organization with private and public partners to achieve BioAgral’s mission: Quebec Ag-biotech network aiming to mobilize all players in this key sector of innovation to promote the Agri-Food, Veterinary and Agri-Environmental Biotechnology.

Manager, Business Intelligence

• 1999 - 2001

Lead several Knowledge Management, Risk Management, Data Mining, international projects for public institutions, multinational firms and CAC 40 groups. Lead several Knowledge Management, Risk Management, Data Mining, international projects for public institutions, multinational firms and CAC 40 groups.

Business Analyst

• 1997 - 1998

Policy Analyst, Blue Book traineeship programme

• 1997 - 1997